Roshanak Aslebagh
About Roshanak Aslebagh
Roshanak Aslebagh is a Scientist II at CytomX Therapeutics with a strong background in mass spectrometry-based proteomics and metabolomics. She has held various academic and research positions, including roles at Clarkson University and the University of Massachusetts Medical School.
Work at CytomX Therapeutics
Roshanak Aslebagh has been employed at CytomX Therapeutics as a Scientist II since 2021. In this role, she contributes to research and development efforts within the organization, focusing on innovative therapeutic solutions. Her position is based in the San Francisco Bay Area, where she applies her extensive knowledge in chemical engineering and mass spectrometry.
Education and Expertise
Roshanak Aslebagh holds a Doctor of Philosophy (Ph.D.) in Biochemistry with a specialization in Mass Spectrometry-Based Proteomics from Clarkson University, which she completed between 2013 and 2017. She also earned a Master's Degree in Chemical Engineering-Biomedical from Tarbiat Modares University from 2010 to 2013, and a Bachelor's Degree in Chemical Engineering from the University of Tehran from 2005 to 2010. Her academic background supports her expertise in mass spectrometry and data analysis.
Background
Prior to her current role, Roshanak Aslebagh worked at the University of Massachusetts Medical School as a Postdoctoral Associate from 2018 to 2021. She also served as a Research Assistant and Teacher Assistant at Clarkson University, where she taught General Chemistry and Biochemistry. Her experience spans several years in academia, contributing to her strong foundation in chemical engineering and biochemistry.
Achievements
Roshanak Aslebagh has developed significant expertise in troubleshooting data analysis issues related to mass spectrometry-based proteomics and metabolomics. She has specialized in LC-MS/MS and nanoUPLC-MS/MS method development, utilizing advanced mass spectrometers such as Orbitrap and QTOF. Her skills include sample preparation and fractionation techniques for complex biological matrices, which are essential in her current research endeavors.